Andreas Kronbichler: The Intronic Splice-Site Variants in Complement-Mediated Thrombotic Microangiopathy
Andreas Kronbichler, Director (Internal Medicine IV, Nephrology and Hypertension), Full Professor at Medizinische Universität Innsbruck, shared a post on LinkedIn about a recent article by Simon Péter Nagy, published in Kidney International Reports, adding:
“The intronic splice-site variants in complement-mediated thrombotic microangiopathy might reveal pathogenic variants that cause the disease.
In a ‘k-and-k’ collaboration, Hungarian-Austrian researchers have expanded our knowledge about c.328plus42G-A carriers and the development of almost complete factor I deficiency, a variant enriched in the CM-TMA database.
This finding further reinforces the relevance of complement genetic analysis in cases with suspected complement-mediated TMA, especially when no identifying cause can be detected!
Just published in the International Society of Nephrology Journal KidneyIntRep, with the contribution of Prof. Rudnicki from our unit.”
Title: Functional Characterization of a Novel Intronic Complement Factor I Variant in Factor I Deficiency and Atypical Hemolytic Uremic Syndrome
Authors: Simon Péter Nagy, Sarolta Dobner, Fanni Szumutku, Alice Schmidt, Gere Sunder-Plassmann, Christof Aigner, Michael Rudnicki, Michal Sedivy, Zoltán Prohászka, Ágnes Szilágyi

Say updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian